Caris Life Sciences, a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a study in Oncotarget validating the analytical and clinical performance of
Pfizer Inc and Astellas Pharma Inc have announced encouraging early results from the Phase 3 EV-303 (KEYNOTE-905) trial. The study evaluated PADCEV (enfortumab vedotin), an
Investment to Drive Commercial Growth, Advance Single-Cell Tri-omics Capabilities and Clinical Applications Across Cancer Mission Bio, a leader in single-cell multi-omics solutions for precision medicine,
First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy Amgen announced that the global
New Initiative Part of Company’s Mission to Move Organizations Across the Healthcare Ecosystem to a More Secure, Compliant, and Resilient StateSo They Can Achieve Their Mission
Leading oncology experts explain the reasons for joining a cancer clinical trial and provide information on how to make it happen. The National Comprehensive Cancer
MSInsight, an innovative start-up specializing in precision medicine in oncology, announces the successful completion of its €1.6 million seed funding round. This fundraising was carried
New research demonstrates that investing an additional 1% of GDP in public healthcare spending, where at least 40% is aimed at preventing and treating NCDs,
clinical trials dramatically underrepresent patients who live in rural areas of the United States. Less than half of US counties (42.4%) had any cancer clinical trials
A national survey conducted by MedStar Health to gauge the public’s knowledge of screening guidelines for colorectal cancer, revealed 79% of the respondents don’t know
Fuel up with free Health Tech Insights
